NEXGEL, INC. Income Taxes Disclosure
21. Income Taxes
The Company has established a full valuation allowance for its deferred tax assets based on management’s belief that it is more likely than not that the related deferred tax assets will be realized. For the years ended December 31, 2025 and 2024, there was income tax expense or benefit.
At December 31, 2025 and 2024, the Company had no recorded tax liabilities for uncertain tax positions. The Company does not expect any significant changes to the estimate amount of liabilities associated with uncertain tax positions in the next 12 months.
The income tax (benefit) provision consists of the following ($ in thousands):
| For The Years Ended | ||||||||
| December 31, | ||||||||
| 2025 | 2024 | |||||||
| Federal: | ||||||||
| Current | $ | (425 | ) | $ | (640 | ) | ||
| Deferred | 425 | 640 | ||||||
| State and local: | ||||||||
| Current | (104 | ) | (161 | ) | ||||
| Deferred | 104 | 161 | ||||||
| Income tax provision | $ | $ | ||||||
For the years ended December 31, 2025 and 2024, the expected tax benefit based on the statutory rate reconciled with the actual benefit is as follows:
For The Years Ended December 31, | ||||||||||||||||
| 2025 | 2024 | |||||||||||||||
| U.S. federal statutory rate | $ | (608 | ) | 21.0 | % | $ | (727 | ) | 21.0 | % | ||||||
| State tax rate, net of federal benefit | (153 | ) | 5.3 | % | (184 | ) | 5.3 | % | ||||||||
| Permanent differences: | ||||||||||||||||
| Non-deductible expenses | 78 | (2.7 | )% | 111 | (3.2 | )% | ||||||||||
| Timing differences | 151 | (5.2 | )% | (1 | ) | — | % | |||||||||
| Change in valuation allowance | 532 | (18.4 | )% | 801 | (23.1 | )% | ||||||||||
| Income tax provision | $ | — | % | $ | — | % | ||||||||||
For the years ended December 31, 2025 and 2024, differences between the expected tax expense based on the federal statutory rate and the actual tax expense is primarily attributable to the net losses incurred and the corresponding increase to the valuation allowance.
As of December 31, 2025 and 2024, the Company’s deferred tax assets consisted of the effects of temporary differences attributable to the following ($ in thousands):
| As of December 31, | ||||||||
| 2025 | 2024 | |||||||
| Deferred tax assets: | ||||||||
| Net operating loss carryforwards | $ | 6,193 | $ | 5,661 | ||||
| Other | 12 | 7 | ||||||
| Total deferred tax assets | 6,205 | 5,668 | ||||||
| Valuation allowance | (6,205 | ) | (5,668 | ) | ||||
| Deferred tax assets, net of valuation allowance | $ | $ | ||||||
As of December 31, 2025 and 2024, the Company has approximately $23.6 million and $21.5 million of federal NOL carryovers, respectively, which begin to expire in 2029 through 2037. Similarly, the subsidiary’s Pennsylvania state returns reported state NOL carryovers of approximately $23.6 million and $21.5 million, as of December 31, 2025 and 2024, respectively. However, these loss carryforwards on a separate company basis may be subject to limitations on the amounts that may be utilized pursuant to Internal Revenue Code section 382 and applicable state law. Section 382 imposes significant limitations on the utilization of net operating losses after certain changes of corporate ownership. The Company will need to determine the amount of loss carryforwards that may be utilized in the future as necessary.
In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of the deferred tax assets is dependent upon the future generation of taxable income during the years in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. After consideration of all the evidence, both positive and negative, management has recorded a full valuation allowance against net deferred tax assets at December 31, 2025 and 2024 because management has determined that it is more likely than not that these deferred tax assets will not be realized.
The Company is subject to taxation in the U.S. and various states. Based on the history of net operating losses all jurisdictions and tax years are open for examination until the operating losses are utilized or the statute of limitations expires. As of December 31, 2025 and 2024, the Company does not have any significant uncertain tax positions.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Mar 31, 2026 | Showing above |
| 2024 | Mar 27, 2025 | |
| 2023 | Apr 10, 2024 | |
| 2022 | Mar 28, 2023 | |
| 2021 | Mar 21, 2022 | |
| 2020 | Mar 31, 2021 | |
| 2019 | Mar 30, 2020 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.